Single User License
INR 168725
Site License
INR 337450
Corporate User License
INR 506175

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Atopic Dermatitis Global Clinical Trials Review, H1

Atopic Dermatitis Global Clinical Trials Review, H1


  Request for Sample Report

Executive Summary

Atopic Dermatitis Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Atopic Dermatitis Global Clinical Trials Review, H1, 2015" provides an overview of Atopic Dermatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Atopic Dermatitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Atopic Dermatitis 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Atopic Dermatitis to Dermatology Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Atopic Dermatitis to Dermatology Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Atopic Dermatitis 25

Subjects Recruited Over a Period of Time 30

Clinical Trials by Sponsor Type 31

Prominent Sponsors 32

Top Companies Participating in Atopic Dermatitis Therapeutics Clinical Trials 33

Prominent Drugs 34

Latest Clinical Trials News on Atopic Dermatitis 35

Jun 08, 2015: Pfizer Announces 12 Presentations Including New Research Data on Tofacitinib for Chronic Plaque Psoriasis and Atopic Dermatitis at World Congress of Dermatology 35

May 05, 2015: Kineta Announces Promising Top-line Clinical Results for Dalazatide; Target Implicated in Broad Array of Autoimmune Diseases 36

May 04, 2015: Aquinox Pharmaceuticals Completes Enrollment in the Phase 2 KINSHIP Trial of AQX-1125 in Atopic Dermatitis 37

Mar 16, 2015: AnGes Starts Phase III Clinical Trials of NF-kB Decoy Oligonucleotide Ointment Drug for Atopic Dermatitis in Japan 37

Clinical Trial Profiles 39

Clinical Trial Overview of Top Companies 39

Novartis AG 39

Clinical Trial Overview of Novartis AG 39

Astellas Pharma Inc. 44

Clinical Trial Overview of Astellas Pharma Inc. 44

Sanofi 46

Clinical Trial Overview of Sanofi 46

Regeneron Pharmaceuticals, Inc. 48

Clinical Trial Overview of Regeneron Pharmaceuticals, Inc. 48

GlaxoSmithKline Plc 50

Clinical Trial Overview of GlaxoSmithKline Plc 50

The LEO Foundation 51

Clinical Trial Overview of The LEO Foundation 51

Johnson & Johnson 52

Clinical Trial Overview of Johnson & Johnson 52

Bayer AG 53

Clinical Trial Overview of Bayer AG 53

Anacor Pharmaceuticals, Inc. 54

Clinical Trial Overview of Anacor Pharmaceuticals, Inc. 54

Sandoz International GmbH 55

Clinical Trial Overview of Sandoz International GmbH 55

Clinical Trial Overview of Top Institutes / Government 56

The National Institute of Allergy and Infectious Diseases 56

Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 56

Wake Forest University 57

Clinical Trial Overview of Wake Forest University 57

Academic Medical Center 58

Clinical Trial Overview of Academic Medical Center 58

Dresden University of Technology 59

Clinical Trial Overview of Dresden University of Technology 59

National Center for Child Health and Development 60

Clinical Trial Overview of National Center for Child Health and Development 60

Oregon Health & Science University 61

Clinical Trial Overview of Oregon Health & Science University 61

University of California, San Diego 62

Clinical Trial Overview of University of California, San Diego 62

Yokohama City University 63

Clinical Trial Overview of Yokohama City University 63

Department of Health, UK 64

Clinical Trial Overview of Department of Health, UK 64

Hospices Civils de Lyon 65

Clinical Trial Overview of Hospices Civils de Lyon 65

Five Key Clinical Profiles 66

Appendix 86

Abbreviations 86

Definitions 86

Research Methodology 87

Secondary Research 87

About GlobalData 88

Contact Us 88

Disclaimer 88

Source 88

List of Figures

Atopic Dermatitis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Atopic Dermatitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Atopic Dermatitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Atopic Dermatitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Atopic Dermatitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Atopic Dermatitis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Atopic Dermatitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13

Atopic Dermatitis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14

Proportion of Atopic Dermatitis to Dermatology Clinical Trials, G7 Countries (%), 2015* 15

Atopic Dermatitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Atopic Dermatitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Atopic Dermatitis to Dermatology Clinical Trials, E7 Countries (%), 2015* 18

Atopic Dermatitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Atopic Dermatitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Atopic Dermatitis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Atopic Dermatitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Atopic Dermatitis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Atopic Dermatitis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Atopic Dermatitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 30

Atopic Dermatitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 31

Atopic Dermatitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 32

Atopic Dermatitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 33

Atopic Dermatitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 34

GlobalData Methodology 87

List of Tables

Atopic Dermatitis Therapeutics, Global, Clinical Trials by Region, 2015* 7

Atopic Dermatitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Atopic Dermatitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Atopic Dermatitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Atopic Dermatitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Atopic Dermatitis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Atopic Dermatitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Atopic Dermatitis Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Atopic Dermatitis to Dermatology Clinical Trials, G7 Countries (%), 2015* 15

Atopic Dermatitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Atopic Dermatitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Atopic Dermatitis to Dermatology Clinical Trials, E7 Countries (%), 2015* 18

Atopic Dermatitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Atopic Dermatitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Atopic Dermatitis Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Atopic Dermatitis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Atopic Dermatitis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Atopic Dermatitis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Atopic Dermatitis Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Atopic Dermatitis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26

Atopic Dermatitis Therapeutics, Global, Terminated Clinical Trials, 2015* 27

Atopic Dermatitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 30

Atopic Dermatitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 31

Atopic Dermatitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 32

Atopic Dermatitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 33

Atopic Dermatitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 34

Atopic Dermatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 39

Atopic Dermatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015* 44

Atopic Dermatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 46

Atopic Dermatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Regeneron Pharmaceuticals, Inc., 2015* 48

Atopic Dermatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015* 50

Atopic Dermatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The LEO Foundation, 2015* 51

Atopic Dermatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015* 52

Atopic Dermatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 53

Atopic Dermatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Anacor Pharmaceuticals, Inc., 2015* 54

Atopic Dermatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sandoz International GmbH, 2015* 55

Atopic Dermatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015* 56

Atopic Dermatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2015* 57

Atopic Dermatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015* 58

Atopic Dermatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Dresden University of Technology, 2015* 59

Atopic Dermatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Child Health and Development, 2015* 60

Atopic Dermatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health & Science University, 2015* 61

Atopic Dermatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2015* 62

Atopic Dermatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Yokohama City University, 2015* 63

Atopic Dermatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, UK, 2015* 64

Atopic Dermatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospices Civils de Lyon, 2015* 65

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Novartis AG

Astellas Pharma Inc.

Sanofi

Regeneron Pharmaceuticals, Inc.

GlaxoSmithKline Plc

The LEO Foundation

Johnson & Johnson

Bayer AG

Anacor Pharmaceuticals, Inc.

Sandoz International GmbH

Atopic Dermatitis Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Atopic Dermatitis, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com